Our study now expands the evidence on the prognostic role of GDF‐15 to patients with cirrhosis by demonstrating a significant link between elevated GDF‐15 and the risk of hepatic decompensation—independently from hepatic dysfunction, portal hypertension severity, as assessed by gold‐standard HVPG measurements, and systemic inflammation. Here, GDF15 is linked to liver disorder.